| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
418,964 |
336,809 |
$38.13M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
44,807 |
38,006 |
$12.58M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
71,945 |
67,935 |
$7.64M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
72,605 |
66,672 |
$4.30M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
37,814 |
35,976 |
$4.22M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
50,924 |
47,022 |
$3.09M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
16,205 |
15,470 |
$2.25M |
| 70450 |
Computed tomography, head or brain; without contrast material |
16,273 |
15,349 |
$1.99M |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
43,889 |
18,730 |
$1.83M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
15,556 |
14,355 |
$1.76M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,748 |
5,483 |
$1.55M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
34,820 |
13,878 |
$1.54M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
18,622 |
14,288 |
$1.54M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29,550 |
27,922 |
$1.36M |
| 59025 |
Fetal non-stress test |
9,387 |
7,040 |
$1.35M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
17,817 |
16,258 |
$1.25M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,044 |
3,948 |
$1.19M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,888 |
5,723 |
$1.10M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,217 |
3,123 |
$1.09M |
| J9271 |
Injection, pembrolizumab, 1 mg |
267 |
191 |
$1.01M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,259 |
6,030 |
$1.00M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
50,862 |
19,628 |
$988K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,528 |
1,507 |
$765K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
9,142 |
8,893 |
$734K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,569 |
3,486 |
$722K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,099 |
2,030 |
$717K |
| 76830 |
Ultrasound, transvaginal |
8,380 |
8,234 |
$701K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,917 |
3,799 |
$636K |
| 77412 |
|
1,380 |
125 |
$623K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
3,096 |
2,295 |
$584K |
| 96415 |
|
3,080 |
1,934 |
$550K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,735 |
3,628 |
$538K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
488 |
389 |
$505K |
| 76801 |
|
9,069 |
8,257 |
$483K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
22,962 |
9,354 |
$470K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
9,438 |
9,278 |
$462K |
| 80053 |
Comprehensive metabolic panel |
111,222 |
93,047 |
$427K |
| 76642 |
|
4,769 |
4,630 |
$420K |
| 17110 |
|
1,910 |
1,799 |
$410K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
7,966 |
4,476 |
$384K |
| 95886 |
|
2,593 |
2,542 |
$368K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,183 |
1,944 |
$365K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
5,564 |
5,349 |
$364K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,191 |
1,138 |
$364K |
| 95806 |
|
712 |
703 |
$355K |
| 12001 |
|
1,877 |
1,846 |
$355K |
| 29125 |
|
2,449 |
2,349 |
$343K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
6,423 |
5,092 |
$325K |
| 12011 |
|
1,492 |
1,459 |
$314K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
22,477 |
9,576 |
$308K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
46,005 |
45,216 |
$305K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,664 |
4,612 |
$305K |
| 90651 |
|
4,133 |
4,101 |
$304K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
8,858 |
8,766 |
$293K |
| 70496 |
|
2,251 |
2,179 |
$293K |
| 10060 |
|
1,609 |
1,562 |
$285K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
580 |
564 |
$281K |
| 76770 |
|
3,354 |
3,279 |
$280K |
| 76536 |
|
3,416 |
3,362 |
$274K |
| 29515 |
|
1,965 |
1,897 |
$273K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
2,220 |
2,164 |
$273K |
| 20611 |
|
1,531 |
1,242 |
$250K |
| 97129 |
|
892 |
377 |
$242K |
| 95812 |
|
684 |
667 |
$228K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,323 |
2,282 |
$214K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,069 |
811 |
$205K |
| 97161 |
|
5,435 |
5,238 |
$204K |
| 93970 |
|
2,261 |
2,187 |
$192K |
| 10061 |
|
889 |
863 |
$191K |
| 93017 |
|
2,041 |
1,970 |
$190K |
| 12002 |
|
1,093 |
1,070 |
$185K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,931 |
3,800 |
$180K |
| 49083 |
|
663 |
288 |
$172K |
| 71046 |
Radiologic examination, chest; 2 views |
25,961 |
24,738 |
$169K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
417 |
406 |
$164K |
| 96367 |
|
4,368 |
2,542 |
$164K |
| Q3014 |
Telehealth originating site facility fee |
6,604 |
6,211 |
$161K |
| 72141 |
|
1,289 |
1,264 |
$160K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
1,775 |
1,136 |
$158K |
| 95800 |
|
1,253 |
1,207 |
$155K |
| 52000 |
|
322 |
302 |
$149K |
| 90686 |
|
18,943 |
18,708 |
$148K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
322 |
304 |
$144K |
| 90715 |
|
8,524 |
8,363 |
$140K |
| 29505 |
|
1,081 |
1,050 |
$140K |
| 97113 |
|
3,334 |
1,397 |
$138K |
| 64615 |
|
563 |
535 |
$136K |
| 76870 |
|
1,594 |
1,551 |
$136K |
| G0378 |
Hospital observation service, per hour |
16,897 |
6,257 |
$133K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
883 |
842 |
$130K |
| 71250 |
|
2,710 |
2,629 |
$125K |
| 36902 |
|
166 |
152 |
$118K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,352 |
3,860 |
$116K |
| J0897 |
Injection, denosumab, 1 mg |
880 |
728 |
$116K |
| 97162 |
|
3,331 |
3,194 |
$115K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
910 |
885 |
$111K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
2,708 |
1,513 |
$109K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
29,863 |
24,570 |
$108K |
| 70491 |
|
950 |
910 |
$105K |
| 84484 |
|
27,464 |
20,250 |
$105K |
| 36430 |
|
1,386 |
998 |
$102K |
| 74183 |
|
604 |
582 |
$101K |
| 70486 |
|
2,684 |
2,635 |
$95K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,379 |
2,186 |
$93K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
11,587 |
9,684 |
$90K |
| 97535 |
Self-care/home management training, each 15 minutes |
5,306 |
3,636 |
$86K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,316 |
1,274 |
$82K |
| 76942 |
|
1,548 |
1,439 |
$81K |
| 90750 |
|
732 |
727 |
$80K |
| 76882 |
|
1,148 |
1,019 |
$80K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,386 |
12,447 |
$77K |
| 77066 |
Tomosynthesis, mammo |
3,059 |
2,958 |
$76K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,364 |
5,623 |
$69K |
| 76813 |
|
2,085 |
2,056 |
$68K |
| 94060 |
|
1,906 |
1,871 |
$67K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
31,600 |
21,589 |
$65K |
| 97116 |
|
5,952 |
2,978 |
$65K |
| 97165 |
|
2,017 |
1,904 |
$64K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
9,127 |
9,031 |
$62K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
52,923 |
46,159 |
$61K |
| 73630 |
|
7,974 |
6,805 |
$60K |
| 77080 |
|
1,990 |
1,957 |
$59K |
| 87040 |
|
8,476 |
5,902 |
$57K |
| 90674 |
|
3,330 |
3,278 |
$57K |
| 76937 |
|
2,433 |
2,083 |
$57K |
| 36415 |
Collection of venous blood by venipuncture |
151,302 |
118,769 |
$57K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
48,097 |
42,967 |
$56K |
| 93971 |
|
813 |
786 |
$55K |
| 77336 |
|
1,237 |
512 |
$54K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,093 |
661 |
$53K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,171 |
1,113 |
$52K |
| 70498 |
|
2,191 |
2,120 |
$52K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,756 |
4,594 |
$52K |
| 90647 |
|
3,978 |
3,947 |
$52K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14,443 |
14,271 |
$51K |
| 20610 |
|
427 |
382 |
$50K |
| 77065 |
Tomosynthesis, mammo |
1,978 |
1,763 |
$50K |
| 99001 |
|
14,890 |
13,690 |
$49K |
| 90670 |
|
5,865 |
5,793 |
$49K |
| 71271 |
|
944 |
926 |
$47K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,761 |
4,556 |
$47K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
125,330 |
104,757 |
$47K |
| 72100 |
|
5,092 |
4,976 |
$47K |
| 47562 |
|
24 |
24 |
$47K |
| 93978 |
|
1,248 |
1,205 |
$46K |
| 95816 |
|
301 |
294 |
$45K |
| 73030 |
|
5,593 |
5,012 |
$41K |
| 44970 |
|
13 |
13 |
$40K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
47 |
38 |
$39K |
| 72040 |
|
2,369 |
2,304 |
$39K |
| 73560 |
|
1,938 |
1,705 |
$37K |
| 83605 |
|
7,725 |
6,347 |
$36K |
| 97763 |
|
409 |
270 |
$35K |
| 73610 |
|
5,898 |
5,455 |
$35K |
| 29540 |
|
295 |
293 |
$35K |
| 73564 |
|
6,324 |
5,638 |
$35K |
| J3490 |
Unclassified drugs |
2,752 |
2,575 |
$34K |
| 74018 |
|
3,776 |
3,525 |
$34K |
| 83880 |
|
9,371 |
8,643 |
$34K |
| 73130 |
|
5,130 |
4,334 |
$32K |
| 64405 |
|
123 |
115 |
$30K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
1,097 |
984 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
24,505 |
22,709 |
$29K |
| 94726 |
|
1,779 |
1,748 |
$28K |
| 94729 |
|
1,844 |
1,809 |
$28K |
| 85380 |
|
5,781 |
5,613 |
$28K |
| 93798 |
|
4,362 |
607 |
$27K |
| 72110 |
|
1,228 |
1,207 |
$27K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
506 |
476 |
$27K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
148 |
49 |
$26K |
| 76820 |
|
821 |
413 |
$25K |
| 90734 |
|
2,116 |
2,101 |
$25K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
14 |
14 |
$24K |
| 64450 |
|
227 |
219 |
$24K |
| 73110 |
|
3,781 |
3,409 |
$23K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
4,095 |
3,886 |
$23K |
| 96523 |
|
807 |
547 |
$22K |
| 73502 |
|
3,069 |
2,918 |
$20K |
| 36591 |
|
2,802 |
2,013 |
$19K |
| 90714 |
|
955 |
938 |
$18K |
| 0134A |
|
692 |
678 |
$18K |
| 72193 |
|
90 |
88 |
$18K |
| 0071A |
|
462 |
460 |
$18K |
| 84145 |
|
2,255 |
2,066 |
$18K |
| 90677 |
|
1,579 |
1,543 |
$18K |
| 0054A |
|
663 |
652 |
$18K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
57 |
39 |
$18K |
| 97035 |
|
2,785 |
1,361 |
$18K |
| 72072 |
|
1,372 |
1,349 |
$17K |
| 36475 |
|
15 |
13 |
$17K |
| 11900 |
|
113 |
106 |
$17K |
| 90688 |
|
1,045 |
1,027 |
$17K |
| 29105 |
|
83 |
82 |
$16K |
| 82728 |
|
3,925 |
3,604 |
$16K |
| 64616 |
|
60 |
53 |
$16K |
| 76818 |
|
423 |
356 |
$16K |
| 0072A |
|
382 |
382 |
$15K |
| 29240 |
|
83 |
80 |
$15K |
| 95819 |
|
50 |
50 |
$15K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
41,494 |
33,838 |
$15K |
| J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
27 |
24 |
$15K |
| 74174 |
|
265 |
254 |
$15K |
| 73140 |
|
2,551 |
2,419 |
$15K |
| 97166 |
|
437 |
411 |
$14K |
| 72156 |
|
141 |
138 |
$14K |
| 69209 |
|
358 |
346 |
$14K |
| 88307 |
|
1,316 |
1,001 |
$13K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
108 |
105 |
$13K |
| 90707 |
|
1,551 |
1,541 |
$13K |
| 72050 |
|
938 |
921 |
$13K |
| 73080 |
|
2,394 |
2,249 |
$13K |
| 85027 |
|
23,254 |
18,582 |
$13K |
| 29130 |
|
80 |
79 |
$12K |
| 64644 |
|
354 |
303 |
$12K |
| 72197 |
|
51 |
50 |
$12K |
| 0064A |
|
499 |
489 |
$12K |
| 58300 |
|
93 |
91 |
$12K |
| 97803 |
|
391 |
286 |
$11K |
| 77001 |
|
252 |
233 |
$11K |
| G0105 |
Colorectal cancer screening; colonoscopy on individual at high risk |
28 |
27 |
$11K |
| 0004A |
|
416 |
415 |
$10K |
| 95909 |
|
477 |
467 |
$10K |
| 76857 |
|
136 |
134 |
$10K |
| 73590 |
|
2,092 |
1,882 |
$10K |
| 51710 |
|
141 |
120 |
$10K |
| 70544 |
|
45 |
45 |
$10K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
193 |
102 |
$10K |
| 95811 |
|
24 |
24 |
$9K |
| 19083 |
|
15 |
15 |
$9K |
| 76821 |
|
269 |
155 |
$9K |
| 0124A |
|
412 |
399 |
$9K |
| 86300 |
|
1,593 |
1,107 |
$9K |
| 29530 |
|
51 |
49 |
$9K |
| 0001A |
|
243 |
235 |
$8K |
| 92557 |
|
149 |
146 |
$8K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
91 |
90 |
$8K |
| 90685 |
|
443 |
442 |
$8K |
| 86923 |
|
1,220 |
1,048 |
$8K |
| 97760 |
|
303 |
279 |
$8K |
| 51705 |
|
102 |
87 |
$7K |
| 51102 |
|
19 |
13 |
$7K |
| 73221 |
|
55 |
51 |
$7K |
| 84466 |
|
3,512 |
3,310 |
$7K |
| 82962 |
|
40,096 |
19,343 |
$7K |
| 74178 |
|
40 |
40 |
$7K |
| J3489 |
Injection, zoledronic acid, 1 mg |
724 |
672 |
$7K |
| 71101 |
|
1,440 |
1,407 |
$7K |
| 82784 |
|
1,164 |
1,005 |
$7K |
| 31575 |
|
27 |
27 |
$7K |
| 97163 |
|
197 |
189 |
$7K |
| 95700 |
|
78 |
77 |
$6K |
| 0011A |
|
200 |
195 |
$6K |
| 83540 |
|
3,529 |
3,321 |
$6K |
| 51702 |
|
1,422 |
1,204 |
$6K |
| 82247 |
|
2,153 |
1,843 |
$6K |
| 72202 |
|
438 |
436 |
$6K |
| 73660 |
|
1,192 |
1,127 |
$6K |
| 99490 |
Ccm add 20min |
458 |
430 |
$6K |
| 90746 |
|
294 |
293 |
$6K |
| 0012A |
|
163 |
161 |
$6K |
| 29580 |
|
26 |
26 |
$6K |
| 64643 |
|
56 |
53 |
$6K |
| 73700 |
|
107 |
102 |
$6K |
| 96402 |
|
1,163 |
814 |
$6K |
| 90656 |
|
1,264 |
1,252 |
$5K |
| J0185 |
Injection, aprepitant, 1 mg |
66 |
37 |
$5K |
| 83735 |
|
15,167 |
11,765 |
$5K |
| 97018 |
|
2,364 |
987 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
22,248 |
12,564 |
$5K |
| 69210 |
|
163 |
161 |
$5K |
| 20552 |
|
46 |
44 |
$5K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
25 |
25 |
$5K |
| 11100 |
|
13 |
13 |
$5K |
| 73090 |
|
1,437 |
1,289 |
$5K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15,738 |
10,980 |
$5K |
| 85018 |
|
4,303 |
3,772 |
$5K |
| 81001 |
|
32,777 |
30,317 |
$5K |
| 0002A |
|
136 |
136 |
$5K |
| 83690 |
|
32,170 |
29,407 |
$5K |
| 73562 |
|
297 |
252 |
$5K |
| 82553 |
|
1,061 |
746 |
$5K |
| 84703 |
|
20,887 |
19,621 |
$5K |
| 58301 |
|
40 |
39 |
$4K |
| 97802 |
|
87 |
87 |
$4K |
| 90713 |
|
317 |
315 |
$4K |
| 84702 |
|
6,605 |
5,844 |
$4K |
| 85610 |
|
36,837 |
26,854 |
$4K |
| 77290 |
|
21 |
15 |
$4K |
| 82378 |
|
1,970 |
1,466 |
$4K |
| 82607 |
|
1,345 |
1,253 |
$4K |
| 10005 |
|
13 |
13 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
30,428 |
28,384 |
$4K |
| 81003 |
|
25,786 |
24,322 |
$4K |
| 20550 |
|
14 |
14 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
5,735 |
5,338 |
$4K |
| 64400 |
|
16 |
15 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15,922 |
14,798 |
$3K |
| 11721 |
|
173 |
169 |
$3K |
| 81025 |
|
16,893 |
16,329 |
$3K |
| 92083 |
|
67 |
67 |
$3K |
| 96416 |
|
109 |
51 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,759 |
4,594 |
$3K |
| 77334 |
|
78 |
65 |
$3K |
| 12013 |
|
12 |
12 |
$3K |
| 92567 |
|
316 |
308 |
$3K |
| 86334 |
|
939 |
827 |
$3K |
| 82248 |
|
2,965 |
2,777 |
$3K |
| 92523 |
|
24 |
24 |
$3K |
| 97130 |
|
783 |
336 |
$3K |
| 74220 |
|
90 |
90 |
$3K |
| 36592 |
|
5,598 |
4,895 |
$3K |
| 86580 |
|
427 |
367 |
$3K |
| 0051A |
|
78 |
78 |
$3K |
| 87070 |
|
3,825 |
3,512 |
$2K |
| 86850 |
|
4,069 |
3,541 |
$2K |
| 0052A |
|
67 |
66 |
$2K |
| 11102 |
|
12 |
12 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,547 |
9,312 |
$2K |
| 82565 |
|
4,687 |
4,211 |
$2K |
| 11982 |
|
12 |
12 |
$2K |
| 88185 |
|
110 |
96 |
$2K |
| 77280 |
|
12 |
12 |
$2K |
| 70360 |
|
135 |
131 |
$2K |
| 86140 |
|
4,600 |
4,045 |
$2K |
| 86900 |
|
4,628 |
3,624 |
$2K |
| 90732 |
|
483 |
458 |
$2K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
399 |
378 |
$2K |
| 90694 |
|
2,087 |
1,982 |
$2K |
| 96376 |
|
14,186 |
10,623 |
$2K |
| J1750 |
Injection, iron dextran, 50 mg |
44 |
26 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
10,525 |
8,107 |
$2K |
| 77300 |
|
31 |
27 |
$2K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
75 |
75 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
6,581 |
6,352 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,811 |
2,624 |
$2K |
| 87081 |
|
4,131 |
3,887 |
$2K |
| 72170 |
|
217 |
207 |
$2K |
| 83615 |
|
1,527 |
1,169 |
$2K |
| 83521 |
|
784 |
677 |
$2K |
| 99495 |
|
121 |
117 |
$2K |
| 86901 |
|
7,498 |
6,690 |
$2K |
| 77077 |
|
132 |
128 |
$2K |
| 84165 |
|
972 |
848 |
$1K |
| 0144A |
|
38 |
38 |
$1K |
| 73060 |
|
463 |
434 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
22,228 |
18,511 |
$1K |
| 99152 |
|
3,897 |
3,575 |
$1K |
| 73552 |
|
387 |
358 |
$1K |
| 96417 |
|
2,593 |
1,517 |
$1K |
| 84100 |
|
3,767 |
2,889 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,009 |
964 |
$1K |
| 83883 |
|
143 |
121 |
$1K |
| 81002 |
|
13,474 |
12,731 |
$1K |
| 36416 |
|
11,265 |
7,166 |
$1K |
| 91321 |
|
55 |
55 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
41,992 |
35,804 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
23,019 |
21,105 |
$1K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
763 |
743 |
$1K |
| 96401 |
|
160 |
49 |
$1K |
| 95910 |
|
61 |
60 |
$1K |
| 92133 |
|
568 |
555 |
$1K |
| 84439 |
|
1,164 |
1,069 |
$1K |
| 90480 |
|
90 |
89 |
$983.52 |
| 82550 |
|
2,771 |
2,306 |
$971.12 |
| 84153 |
|
847 |
675 |
$970.94 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
21,806 |
19,258 |
$967.45 |
| 84155 |
|
2,293 |
1,986 |
$963.55 |
| 0074A |
|
23 |
23 |
$929.60 |
| 85730 |
|
6,833 |
6,242 |
$922.06 |
| 85007 |
|
3,798 |
3,473 |
$873.05 |
| 90474 |
|
2,805 |
2,784 |
$830.43 |
| J2997 |
Injection, alteplase recombinant, 1 mg |
28 |
25 |
$820.40 |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
13 |
13 |
$796.57 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
380 |
360 |
$750.00 |
| 82803 |
|
2,450 |
2,102 |
$735.14 |
| 85652 |
|
3,440 |
3,245 |
$732.09 |
| 64447 |
|
40 |
40 |
$727.14 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
973 |
859 |
$719.71 |
| 87186 |
|
4,724 |
4,142 |
$696.67 |
| 51798 |
|
1,575 |
1,474 |
$689.43 |
| 87205 |
|
3,620 |
3,141 |
$683.09 |
| 87210 |
|
3,405 |
3,310 |
$668.49 |
| 92136 |
|
44 |
41 |
$658.39 |
| 0111A |
|
17 |
17 |
$652.00 |
| 74230 |
|
13 |
12 |
$651.75 |
| J2785 |
Injection, regadenoson, 0.1 mg |
815 |
779 |
$644.82 |
| 90700 |
|
2,043 |
2,031 |
$632.66 |
| 73523 |
|
36 |
36 |
$632.40 |
| 90662 |
|
682 |
677 |
$632.10 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
11,974 |
10,555 |
$614.90 |
| 97597 |
|
14 |
12 |
$587.18 |
| 82746 |
|
299 |
280 |
$574.54 |
| 0112A |
|
13 |
13 |
$569.20 |
| 88184 |
|
125 |
112 |
$564.24 |
| 76981 |
|
14 |
14 |
$541.49 |
| 80061 |
Lipid panel |
570 |
528 |
$536.34 |
| 0141A |
|
13 |
13 |
$516.40 |
| V2632 |
Posterior chamber intraocular lens |
156 |
114 |
$485.98 |
| 88342 |
|
2,507 |
2,175 |
$478.13 |
| 88304 |
|
2,680 |
2,395 |
$472.77 |
| 80177 |
|
271 |
249 |
$469.99 |
| 97012 |
|
70 |
27 |
$465.91 |
| 80051 |
|
766 |
642 |
$464.51 |
| 87088 |
|
3,090 |
2,701 |
$454.22 |
| 0053A |
|
17 |
17 |
$450.80 |
| 90710 |
|
2,235 |
2,222 |
$448.78 |
| 91322 |
|
13 |
13 |
$440.60 |
| 87340 |
|
653 |
597 |
$425.38 |
| 72052 |
|
18 |
16 |
$424.21 |
| 90633 |
|
3,651 |
3,634 |
$407.99 |
| 87147 |
|
1,838 |
1,618 |
$380.62 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,706 |
1,112 |
$367.02 |
| 87077 |
|
2,196 |
1,811 |
$359.23 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
57 |
49 |
$357.84 |
| 97750 |
|
44 |
42 |
$353.15 |
| 84550 |
|
1,889 |
1,567 |
$349.94 |
| 90716 |
|
1,590 |
1,577 |
$341.11 |
| 94664 |
|
69 |
62 |
$338.83 |
| 85014 |
|
1,049 |
708 |
$330.89 |
| 84156 |
|
948 |
799 |
$314.93 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
3,152 |
2,975 |
$312.13 |
| 74022 |
|
65 |
65 |
$310.58 |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
14 |
13 |
$307.58 |
| 84132 |
|
2,841 |
2,380 |
$304.56 |
| 99153 |
Mod sedat endo service >5yrs |
2,051 |
1,887 |
$283.56 |
| 82040 |
|
1,000 |
831 |
$269.67 |
| 92134 |
|
247 |
231 |
$268.20 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
2,748 |
2,260 |
$265.74 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15,726 |
12,158 |
$260.83 |
| 82010 |
|
1,523 |
1,330 |
$253.03 |
| 97014 |
|
24 |
12 |
$239.03 |
| 85046 |
|
241 |
224 |
$233.67 |
| 86304 |
|
70 |
61 |
$230.97 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
11,164 |
9,191 |
$229.88 |
| 82570 |
|
1,000 |
875 |
$227.17 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,939 |
1,798 |
$225.08 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
22,445 |
18,261 |
$223.49 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,258 |
1,208 |
$214.55 |
| 92610 |
|
13 |
13 |
$214.50 |
| 80076 |
|
76 |
70 |
$208.06 |
| 82947 |
|
888 |
760 |
$195.32 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
296 |
279 |
$181.81 |
| 95874 |
|
1,056 |
932 |
$169.00 |
| 85520 |
|
930 |
778 |
$155.99 |
| 74021 |
|
32 |
32 |
$147.48 |
| 84460 |
|
909 |
773 |
$146.54 |
| 84450 |
|
910 |
770 |
$146.37 |
| 82360 |
|
14 |
12 |
$139.13 |
| 86317 |
|
103 |
93 |
$135.73 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
4,009 |
3,271 |
$135.41 |
| 88341 |
|
1,199 |
707 |
$132.28 |
| 84520 |
|
857 |
728 |
$131.56 |
| 72020 |
|
13 |
12 |
$127.21 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,879 |
2,478 |
$111.46 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
25 |
25 |
$105.72 |
| J2060 |
Injection, lorazepam, 2 mg |
5,413 |
4,640 |
$104.29 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,280 |
5,570 |
$100.80 |
| J1644 |
Injection, heparin sodium, per 1000 units |
13,034 |
5,649 |
$95.05 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,583 |
2,383 |
$95.02 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
5,246 |
4,527 |
$93.90 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,548 |
9,488 |
$84.65 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,464 |
2,101 |
$77.25 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
94 |
88 |
$75.00 |
| 88112 |
|
14 |
13 |
$72.97 |
| 76376 |
|
422 |
415 |
$67.87 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
18 |
18 |
$62.51 |
| 86780 |
|
85 |
76 |
$62.08 |
| 87075 |
|
452 |
367 |
$61.72 |
| 90723 |
|
3,401 |
3,372 |
$58.94 |
| 51703 |
|
14 |
14 |
$56.86 |
| C1769 |
Guide wire |
4,112 |
3,750 |
$56.54 |
| 99406 |
|
690 |
665 |
$55.29 |
| 82140 |
|
106 |
86 |
$54.45 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15,508 |
14,282 |
$52.96 |
| 87324 |
|
83 |
78 |
$52.44 |
| C1776 |
Joint device (implantable) |
104 |
103 |
$44.92 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,699 |
1,927 |
$37.44 |
| 93356 |
|
471 |
463 |
$36.69 |
| 91301 |
|
419 |
405 |
$36.30 |
| 87449 |
|
96 |
91 |
$31.92 |
| 89050 |
|
56 |
52 |
$29.78 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
3,247 |
3,075 |
$25.93 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,625 |
2,006 |
$23.17 |
| 72070 |
|
25 |
25 |
$22.60 |
| 36600 |
|
113 |
67 |
$21.68 |
| 87184 |
|
207 |
189 |
$20.42 |
| 72220 |
|
13 |
13 |
$20.40 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,627 |
1,404 |
$19.36 |
| A4648 |
Tissue marker, implantable, any type, each |
316 |
289 |
$18.35 |
| 90672 |
|
93 |
93 |
$16.34 |
| 94760 |
|
1,844 |
1,404 |
$16.04 |
| J1953 |
Injection, levetiracetam, 10 mg |
334 |
269 |
$15.77 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
147 |
107 |
$12.00 |
| 80305 |
|
14 |
13 |
$8.51 |
| 82948 |
|
44 |
23 |
$7.83 |
| 86703 |
|
80 |
80 |
$7.16 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
3,156 |
2,898 |
$7.04 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,040 |
859 |
$5.71 |
| 82310 |
|
60 |
56 |
$5.29 |
| G0008 |
Administration of influenza virus vaccine |
5,300 |
4,897 |
$4.80 |
| 90653 |
|
383 |
374 |
$4.44 |
| A9270 |
Non-covered item or service |
95,009 |
17,319 |
$4.19 |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,687 |
1,918 |
$4.09 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,040 |
951 |
$3.86 |
| J1790 |
Injection, droperidol, up to 5 mg |
121 |
115 |
$3.54 |
| 82435 |
|
60 |
56 |
$3.51 |
| 82374 |
|
60 |
56 |
$3.51 |
| 84295 |
|
61 |
57 |
$3.51 |
| J3411 |
Injection, thiamine hcl, 100 mg |
351 |
206 |
$3.06 |
| J1836 |
Injection, metronidazole, 10 mg |
153 |
98 |
$2.95 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
689 |
649 |
$2.36 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
395 |
380 |
$2.28 |
| C1758 |
Catheter, ureteral |
36 |
36 |
$2.09 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,281 |
1,236 |
$1.84 |
| 84075 |
|
42 |
40 |
$1.73 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
534 |
442 |
$1.59 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,546 |
1,299 |
$1.36 |
| J3360 |
Injection, diazepam, up to 5 mg |
161 |
138 |
$1.30 |
| 87807 |
|
348 |
341 |
$1.28 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,957 |
1,837 |
$0.90 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
4,460 |
1,449 |
$0.86 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
636 |
501 |
$0.77 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
468 |
337 |
$0.77 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
146 |
91 |
$0.70 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
1,075 |
937 |
$0.36 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
75 |
75 |
$0.30 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
377 |
303 |
$0.24 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
69 |
66 |
$0.17 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,541 |
895 |
$0.13 |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
100 |
99 |
$0.02 |
| 91307 |
|
959 |
895 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
125 |
109 |
$0.00 |
| 90619 |
|
838 |
831 |
$0.00 |
| 96411 |
|
692 |
401 |
$0.00 |
| 90696 |
|
1,572 |
1,561 |
$0.00 |
| 90697 |
|
1,435 |
1,429 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
848 |
587 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
1,541 |
1,410 |
$0.00 |
| 91314 |
|
51 |
51 |
$0.00 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
278 |
264 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
54 |
50 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
37 |
37 |
$0.00 |
| 91305 |
|
946 |
919 |
$0.00 |
| 82043 |
|
90 |
73 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
523 |
480 |
$0.00 |
| 91306 |
|
496 |
486 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
449 |
256 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
163 |
134 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
412 |
365 |
$0.00 |
| 87486 |
|
88 |
84 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
139 |
66 |
$0.00 |
| C1781 |
Mesh (implantable) |
195 |
185 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
891 |
664 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
115 |
111 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
102 |
64 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
379 |
366 |
$0.00 |
| 95911 |
|
38 |
38 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
139 |
115 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
449 |
392 |
$0.00 |
| 85651 |
|
64 |
51 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
213 |
164 |
$0.00 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
239 |
231 |
$0.00 |
| 87046 |
|
13 |
13 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
287 |
275 |
$0.00 |
| 96368 |
|
215 |
119 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
12 |
12 |
$0.00 |
| 87581 |
|
88 |
84 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
60 |
59 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
69 |
66 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$0.00 |
| 90744 |
|
17 |
17 |
$0.00 |
| 86803 |
|
33 |
28 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
95 |
36 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
18 |
17 |
$0.00 |
| G0379 |
Direct admission of patient for hospital observation care |
13 |
12 |
$0.00 |
| 90381 |
|
19 |
19 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
12 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
697 |
644 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
608 |
575 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
315 |
296 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
293 |
282 |
$0.00 |
| 90681 |
|
3,014 |
2,985 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
344 |
299 |
$0.00 |
| 91300 |
|
850 |
817 |
$0.00 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
80 |
77 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
140 |
105 |
$0.00 |
| 91313 |
|
691 |
677 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
133 |
125 |
$0.00 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
23 |
16 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
137 |
128 |
$0.00 |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
70 |
37 |
$0.00 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
248 |
115 |
$0.00 |
| 90473 |
|
56 |
56 |
$0.00 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
12 |
12 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
393 |
112 |
$0.00 |
| 87045 |
|
13 |
13 |
$0.00 |
| 88313 |
|
49 |
25 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
48 |
31 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
140 |
130 |
$0.00 |
| 83970 |
|
14 |
14 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
261 |
62 |
$0.00 |
| 91311 |
|
112 |
111 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
49 |
42 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
16 |
13 |
$0.00 |
| 89051 |
|
29 |
24 |
$0.00 |
| 31720 |
|
43 |
30 |
$0.00 |
| 88173 |
|
30 |
24 |
$0.00 |
| 87427 |
|
20 |
13 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
27 |
25 |
$0.00 |
| 91312 |
|
412 |
399 |
$0.00 |
| 85384 |
|
13 |
12 |
$0.00 |
| 16020 |
|
13 |
12 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
45 |
44 |
$0.00 |
| 88360 |
|
46 |
26 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
18 |
14 |
$0.00 |
| 98927 |
|
13 |
13 |
$0.00 |